<VariationArchive VariationID="432598" VariationName="NM_144997.7(FLCN):c.932del (p.Pro311fs)" VariationType="Deletion" Accession="VCV000432598" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2017-08-20" MostRecentSubmission="2023-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="426204" VariationID="432598">
      <GeneList>
        <Gene Symbol="FLCN" FullName="folliculin" GeneID="201163" HGNC_ID="HGNC:27310" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="17212212" stop="17237330" display_start="17212212" display_stop="17237330" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="17115525" stop="17140501" display_start="17115525" display_stop="17140501" Strand="-" />
          </Location>
          <OMIM>607273</OMIM>
          <Haploinsufficiency last_evaluated="2023-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLCN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLCN">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_144997.7(FLCN):c.932del (p.Pro311fs)</Name>
      <CanonicalSPDI>NC_000017.11:17219148:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="17219149" stop="17219149" display_start="17219149" display_stop="17219149" variantLength="1" positionVCF="17219148" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="17122463" stop="17122463" display_start="17122463" display_stop="17122463" variantLength="1" positionVCF="17122462" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P311fs</ProteinChange>
      <ProteinChange>P329fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_325" sequenceAccession="LRG_325" change="g.23040del">
            <Expression>LRG_325:g.23040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_325t1" sequenceAccession="LRG_325t1" change="c.932del">
            <Expression>LRG_325t1:c.932del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.17122466del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.17122466del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.17219152del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.17219152del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008001.2" sequenceAccession="NG_008001" sequenceVersion="2" change="g.23040del">
            <Expression>NG_008001.2:g.23040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353229.2" sequenceAccession="NM_001353229" sequenceVersion="2" change="c.986del">
            <Expression>NM_001353229.2:c.986del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340158.1" sequenceAccession="NP_001340158" sequenceVersion="1" change="p.Pro329fs">
            <Expression>NP_001340158.1:p.Pro329fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353230.2" sequenceAccession="NM_001353230" sequenceVersion="2" change="c.932del">
            <Expression>NM_001353230.2:c.932del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340159.1" sequenceAccession="NP_001340159" sequenceVersion="1" change="p.Pro311fs">
            <Expression>NP_001340159.1:p.Pro311fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353231.2" sequenceAccession="NM_001353231" sequenceVersion="2" change="c.932del">
            <Expression>NM_001353231.2:c.932del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340160.1" sequenceAccession="NP_001340160" sequenceVersion="1" change="p.Pro311fs">
            <Expression>NP_001340160.1:p.Pro311fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144997.7" sequenceAccession="NM_144997" sequenceVersion="7" change="c.932del" MANESelect="true">
            <Expression>NM_144997.7:c.932del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_659434.2" sequenceAccession="NP_659434" sequenceVersion="2" change="p.Pro311fs">
            <Expression>NP_659434.2:p.Pro311fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645373074" DB="ClinGen" />
        <XRef Type="rs" ID="1555608617" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_144997.7(FLCN):c.932del (p.Pro311fs) AND not provided" Accession="RCV000497917" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-06-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144997.7(FLCN):c.932del (p.Pro311fs) AND Birt-Hogg-Dube syndrome" Accession="RCV003449394" Version="1">
        <ClassifiedConditionList TraitSetID="860">
          <ClassifiedCondition DB="MedGen" ID="C0346010">Birt-Hogg-Dube syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-08-20" MostRecentSubmission="2023-12-24">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2023-12-23">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="860" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1028" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Birt Hogg Dubé syndrome</ElementValue>
                <XRef ID="1263460007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Birt-Hogg-Dube syndrome</ElementValue>
                <XRef ID="MONDO:0800444" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BHD syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BHD</ElementValue>
                <XRef Type="MIM" ID="135150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical characteristics of Birt-Hogg-Dubé syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, acrochordons, angiofibromas, oral papules, cutaneous collagenomas, and epidermal cysts), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear between the second and fourth decades of life and typically increase in size and number with age. Lung cysts are often bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that can be bilateral and multifocal; median age of renal tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor(s) and/or spontaneous pneumothorax without cutaneous manifestations.</Attribute>
                <XRef ID="NBK1522" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2322" />
                <XRef ID="2322" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301695</ID>
                <ID Source="BookShelf">NBK1522</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Renal cell carcinoma genetics">
                <ID Source="PubMed">26389510</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Birt-Hogg-Dubé syndrome">
                <URL>https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics/bhd-syndrome</URL>
                <CitationText>PDQ® Cancer Genetics Editorial Board. PDQ Birt-Hogg-Dubé Syndrome. Bethesda, MD: National Cancer Institute. Updated &lt;03/08/2021&gt;. Accessed &lt;05/05/2021&gt;.</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="122" DB="Orphanet" />
              <XRef ID="C0346010" DB="MedGen" />
              <XRef ID="MONDO:0800444" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS135150" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1143989" SubmissionDate="2019-01-29" DateLastUpdated="2017-08-20" DateCreated="2017-08-20">
        <ClinVarSubmissionID localKey="GDX:1686657|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000590345" DateUpdated="2017-08-20" DateCreated="2017-08-20" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.932delC variant in the FLCN gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This deletion causes a frameshift starting with codon Proline 311, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 12 of the new reading frame, denoted p.Pro311LeufsX12. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Based on currently available evidence, c.932delC is a strong candidate for a pathogenic variant. However, the possibility it may be a rare benign variant cannot be excluded.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.932delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7825932" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="101796358|OMIM:135150" />
        <ClinVarAccession Accession="SCV004188119" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="17" alternateAllele="A" referenceAllele="AG" start="17122462" stop="17122463" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">101796358</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7825932" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1143989" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

